Andlauer Healthcare Group Inc (AND.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 70,934 | 68,149 | 64,452 | 42,716 | 28,022 |
| Income taxes - deferred | -5,095 | -4,429 | -2,045 | -3,795 | -6,271 |
| Accounts receivable | -6,602 | -4,109 | -2,855 | -14,184 | -3,040 |
| Accounts payable and accrued liabilities | 2,272 | -1,011 | 1,485 | 4,449 | -948 |
| Other Working Capital | -9,028 | -26,939 | -3,076 | -6,252 | -11,595 |
| Other Operating Activity | 71,921 | 72,758 | 79,167 | 61,157 | 44,835 |
| Operating Cash Flow | $124,402 | $104,419 | $137,128 | $84,091 | $51,003 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,036 | -21,779 | -24,027 | -7,768 | -4,965 |
| Net Acquisitions | N/A | 0 | -19,318 | -173,972 | -14,933 |
| Purchase Sale Intangibles | -2,819 | -2,069 | -2,212 | -1,642 | -473 |
| Investing Cash Flow | $-18,855 | $-23,848 | $-45,557 | $-183,382 | $-20,371 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 30,000 | 0 | -11,000 | 11,000 | -3,929 |
| Debt Issued | N/A | N/A | 0 | 25,000 | 0 |
| Debt Repayment | -31,043 | -52,952 | -29,034 | -25,109 | -20,736 |
| Common Stock Issued | N/A | N/A | 0 | 97,051 | 0 |
| Common Stock Repurchased | -106,673 | -18,840 | N/A | N/A | N/A |
| Dividend Paid | -16,723 | -14,202 | -10,883 | -7,854 | -7,929 |
| Other Financing Activity | -1,803 | -188 | -670 | -6,199 | 13,398 |
| Financing Cash Flow | $-126,242 | $-86,182 | $-51,587 | $93,889 | $-19,196 |
| Exchange Rate Effect | 1,438 | -504 | 881 | 244 | N/A |
| Beginning Cash Position | 59,740 | 65,855 | 24,990 | 30,148 | 18,712 |
| End Cash Position | 40,483 | 59,740 | 65,855 | 24,990 | 30,148 |
| Net Cash Flow | $-20,695 | $-5,611 | $39,984 | $-5,402 | $11,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | 124,402 | 104,419 | 137,128 | 84,091 | 51,003 |
| Capital Expenditure | -20,378 | -25,592 | -27,960 | -9,668 | -5,439 |
| Free Cash Flow | 104,024 | 78,827 | 109,168 | 74,423 | 45,564 |